Japan-Israel Hi-Tech Ventures
Overview
Japan-Israel Hi-Tech Ventures is a series of venture capital funds managed by Singapore-based asset management firm The Chartered Group. The series includes at least two funds: Japan Israel High Tech Ventures 1 (JIHTV1), a 2019 vintage fund, and Japan Israel High Tech Ventures 2 (JIHTV2), a 2021 vintage fund. JIHTV1 focuses on early-stage startups, particularly those from Tel Aviv University. JIHTV2 focuses on deep tech companies in sectors like healthy aging, connectivity, automation, and environmental tech, and has a strategic partnership with the Israeli Ministry of Defense's R&D agency, MAFAT. The funds invest in companies in Israel and Japan.
Portfolio Companies
2
Website
charteredgroup.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| X-trodes | Oct 2021 | Seed | Lead |
| Amai Proteins | Sep 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Japan-Israel Hi-Tech Ventures based?
Japan-Israel Hi-Tech Ventures is headquartered in Singapore, Central Singapore, Singapore.
When was Japan-Israel Hi-Tech Ventures founded?
Founding year information for Japan-Israel Hi-Tech Ventures is not publicly available.
How many portfolio companies does Japan-Israel Hi-Tech Ventures have?
Japan-Israel Hi-Tech Ventures has 2 portfolio companies in Caplight's dataset.
What are some companies in Japan-Israel Hi-Tech Ventures's portfolio?
Portfolio companies visible on Caplight include X-trodes, Amai Proteins.
What was Japan-Israel Hi-Tech Ventures's most recent investment shown here?
Japan-Israel Hi-Tech Ventures's most recent investment in this portfolio sample was in X-trodes in 2021.
What sectors does Japan-Israel Hi-Tech Ventures focus on?
Japan-Israel Hi-Tech Ventures focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Japan-Israel Hi-Tech Ventures focus on?
Japan-Israel Hi-Tech Ventures typically invests at the Early stage.